In order to determine whether reduced expression of the IL10R might explain the lower anti-inflammatory function of IL10 in patients with T2D we performed flow cytometry experiments to analyze the surface protein expression of the IL10R1 on “classic” CD14+/CD16- monocytes and “pro-inflammatory” CD14+/CD16+ monocytes. The gene discussed is IL10; the disease is type 2 diabetes mellitus.